Authors:
EVANS J
YOCUM DE
MARICIC M
GLUCK O
TESSER J
CHEN Z
BAYLINK DJ
FLETCHER MP
Citation: J. Evans et al., RESULTS OF AN OPEN-LABEL, DOSE-RANGING, SAFETY AND PHARMACOKINETIC TRIAL OF THE HUMANIZED TUMOR-NECROSIS-FACTOR ANTIBODY (HTA), BAY-103356,IN PATIENTS WITH ACTIVE RHEUMATOID-ARTHRITIS (RA), Arthritis and rheumatism, 40(9), 1997, pp. 1158-1158
Authors:
GROSSMAN RS
MURATA GH
FINCHER RME
NORCINI JJ
KAPSNER C
LAYNE RD
SEELIG CB
GATELEY A
ARKY R
BERKOWITZ L
CAIN P
CARLISI J
DELGADO D
FISHER R
FRYE E
GROSSMAN R
HABURCHAK D
HARDESTY D
KENNEDY J
KOUNTZ D
LAVIS V
LAYNE R
LAYSON R
LEVINE M
MARICIC M
MURATA G
NOAH M
POTTS D
RUCKER L
SEELIG C
SIMONS R
WALKER HK
YODER E
Citation: Rs. Grossman et al., PREDICTING PERFORMANCE ON THE AMERICAN BOARD OF INTERNAL-MEDICINE CERTIFYING EXAMINATION - THE EFFECTS OF RESIDENT PREPARATION AND OTHER FACTORS, Academic medicine, 71(10), 1996, pp. 74-76
Citation: D. Burks et al., REPEAT BONE DENSITOMETRY AFFECTS PATIENTS DECISIONS TO CONTINUE OSTEOPOROSIS MEDICATION, Journal of bone and mineral research, 10, 1995, pp. 249-249
Citation: D. Burks et M. Maricic, LATERAL LUMBAR BMD IS ASSOCIATED WITH AP LUMBAR BMD EVEN IN OLDER PATIENTS, Journal of bone and mineral research, 10, 1995, pp. 274-274
Citation: D. Burks et al., REPEAT BONE DENSITOMETRY AFFECTS PATIENTS DECISIONS TO CONTINUE OSTEOPOROSIS MEDICATION, Arthritis and rheumatism, 38(9), 1995, pp. 1224-1224